Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2757-2762

  Asakawa, Hideki ^a   Kobayashi, Tetsuro ^a   Komoike, Yoshifumi ^a   Maruyama, Hirohide ^b   Nakano, Yoshiaki ^a   Tamaki, Yasuhiro ^a   Matsuzawa, Yuji ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Osaka Teishin Hospital   (Japan)

Author keywords

Chemotherapy; In vitro chemosensitivity; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030755649     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kim JH, Leeper RD: Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy: A new approach. Cancer 52: 954-957, 1983.
2. Tennvall J, Lundell G, Hallquist A, Wahlberg P, Wallin G, Tibblin S: Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Cancer 74: 1348-1354, 1994.
3. Kobayashi T, Asakawa H, Umeshita K et al: Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head & Neck 18: 36-41, 1996.
4. Tan RK, Finley III RK, Driscoll D, Bakamjian V, Hicks WLJr, Shedd DP: Anaplastic carcinoma of the thyroid: A 24-year experience. Head & Neck 17: 41-48, 1995.
5. Hoskin PJ, Harmer C: Chemotherapy for thyroid cancer. Radiother Onco 10: 187-194, 1987.
6. Hadar T, Mor C, Shvero J, Levy R, Segal K: Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 19: 511-516, 1993.
7. De-Besi P, Busnardo B, Toso S et al: Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest 14: 475-480, 1991.
8. Ahuja S, Ernst RD: Chemotherapy of thyroid carcinoma. J Endocrinol Invest 10: 303-310, 1987.
9. Kobayashi T, Asakawa H, Tamaki Y, Umeshita K, Monden M: Fatal differentiated thyroid cancer. J Surg Oncol 62: 123-127, 1996.
10. Gottlieb JA, Hill CSJr: Chemotherapy of thyroid cancer with adriamycin, Experience with 30 patients. N Engl J Med 290: 193-197, 1974.
11. Shimaoka K, Schoenfeld DA, Dewys LH: A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56: 2155-2160, 1985.
12. Asakawa H, Kobayashi T, Komoike Y et al: Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis. J Clin Endocrinol Metab 81: 3547-3552, 1996.
13. Carmichael J, Mitchell JB, DeGraff WG et al: Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 57: 540-547, 1988.
14. Smith HS, Zoli W, Volpi A, et al: Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells. Cancer Res 50: 2943-2948, 1990.
15. Ajani JA, Baker FL, Spitzer G et al: Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. J Clin Oncol 5: 1912-1921, 1987.
16. Kitamura M, Furukawa H, Kito T et al: Chemosensitivity of gastric cancer using adhesive tumor cell culture system. Oncol Rep 2: 27-31, 1995.
17. Fan D, Ajani J, Baker FL, Tomascovic B, Brock WA, Spitzer G: Comparison of anti-tumor activity of standard and investigational drugs at equivalent granulocyte-macrophage colony forming cell inhibitory concentrations in the adhesive tumor cell culture system: An in vitro method of screening new drugs. Eur J Cancer Clin Oncol 23: 1469-1476, 1987.
18. Maruyama K, Unezaki S, Takahashi N, Iwatsuru M: Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta 1149: 209-216, 1993.
19. Tsai CM, Gazdar AF, Venzon DJ et al: Lack of in vitro synergy between etoposide and cis-diammine-dichloroplatinum. Cancer Res 49: 2390-2397, 1989.